Navigation Links
New Canadian study finds drug coated heart stents to be safe:
Date:10/3/2007

and the University of Toronto, says, "Physicians implanting the devices need to ensure patients who get a drug-eluting stent also take anti-clotting medication such as aspirin and clopidogrel (antiplatelet therapy) for a minimum of one year after the angioplasty procedure. This therapy reduces the risk of fatal blood clots associated with drug-eluting stents. This prolonged period of clopidogrel usage could explain differences between results in Ontario, compared to those from other countries, such as Sweden. In our study, these medications were made available to all elderly patients in Ontario, at minimal cost, through the Ontario Drug Benefits Program for one year after the angioplasty procedure."

Since their introduction in 2003, more than six million heart patients worldwide have received a drug-eluting stent (DES). The DES market is worth $5 billion a year, costing about $2300 for a DES versus $700 for a bare metal stent (BMS). The rate of DES use in countries like the United States was as high as 90% but dropped to about 70% in the past year, after recent controversy over safety. Recent studies from Europe and Sweden suggest DES may increase mortality and heart attack after a coronary angioplasty. The rate of DES usage in Ontario was on average 38% of all stents during the study period. In 2003, the Ontario government approved the introduction of DES provincially, conditional upon an independent evaluation of their effectiveness and cost-effectiveness. Approximately 20,000 angioplasties are performed each year in the province of Ontario.

The study "Effectiveness and safety of drug-eluting stents in Ontario" is in the October 4th issue of the New England Journal of Medicine. The study was funded by operating grants from the Ontario Ministry of Health and Long-term Care and a Canadian Institutes of Health Research Team Grant in Cardiovascular Outcomes Research.

Author affiliations: ICES (J.V.T., M.C., D.T.K., P.C.A., Y.H.) and Sunnybrook Healt
'/>"/>

SOURCE Institute for Clinical Evaluative Sciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Frozen Canadian baby stages miraculous recovery
2. Canadian Street Prostitutes Requests Protection
3. Rural Canadians travel far for specialists: study
4. Canadian Youth at risk of heart disease
5. Canadians flocking to India for quick and efficient medical treatment
6. CPHA Offers HIV Information Packages To Canadian Football League Teams
7. Insomnia Hits Many Canadians: Survey
8. Canadians Oblivious About COPD, A Debilitating Lung Disease
9. Disparity In Survival Rates In US and Canadian heart Patients
10. Canadian health on the decline, due to a drinking problem
11. Lack of facilities in emergency rooms, warn Canadian nurses!

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)..., "One victory does not mean the battle is won,.... 7 In a vote of 240-19...pinski-Smith Amendment to prohibit abortion mandat...r. ,, Americans United for Life Action Presiden...f this amendment is a victory for the pro-life Ame...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ... Director, Operation Rescue Insurrecta Nex. ,,...try have been fighting to keep child-killing by ab..., Mr. Terry states: "This is a great first step t...ut we have a lot of fighting ahead of us. Our rejo...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 ...th Insurance Plans (AHIP), released the following ..., "Health plans strongly support comprehensive he...discussion by proposing a complete overhaul of how...we proposed guaranteed coverage, elimination of pr...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling this a...ation (AMA), the AMA President J. James Rohack, M....ysicians from all state and medical specialty soci...cy-making meeting, where health system reform will....com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Over...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 ... press availability this afternoon following a Dem...annon Caucus Room. Below are the Speaker,s openin... Yes, it was a great occasion for us to receive th...we will be making history with our vote and making...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2
...s., Oct. 20 Psychemedics,Corporation (Nasdaq: PM...ed,the company as Vice President, Controller., Ra...l financial,reporting activities, as well as the f..., Ray has served as Director of International Fina...
...of Silicon Merges High-Performance Data Conversion...ompression, SANTA CLARA, Calif., Oct. 20 Samplif...on solutions, today announces its move,from intell...se: Samplify Announces SAM1600 Family) Samplify ma...
... OCI Adds Two National Sales Repre... Denver, CO (PRWEB) October 20, 2008 -- OCI, ...risk management , HR and employee benefits leade...Lenox, based in Chicago, Illinois., , ,“Kell...
... The Florida Academy of Cosmetic D...ery Competition to Sarasota cosmetic dentist Dr. C... Florida (PRWEB) October 20, 2008 -- The Sarasota...y Competition., , ,The FACD Smile Gallery competit...
...s a member of PPI class for treatment for GERD and... OSAKA, Japan, Oct. 20 Takeda Pharmaceutical Com...a Global Research and,Development Center, Inc., a ...o complete its review of the TAK-390MR New,Drug Ap...
...sts at the Gladstone Institute of Neurological Dis...found that complete or partial removal of an enzym...ive deficits in a mouse model of Alzheimer,s disea... disease as well as a novel therapeutic strategy. ...
Other Medicine News:Health News:Raymond J. Ruddy Joins Psychemedics Corporation As Top Financial Officer 2Health News:Samplify Evolves Business Model From IP Developer to Semiconductor Supplier; Now Targets Multi-Billion Dollar Market 2Health News:Employee Benefits and Risk Management Solutions Provider OCI Appoints Two New Representatives to Its Sales Team 2Health News:Sarasota Cosmetic Dentistry Practice Wins Big At FACD 2Health News:FDA Adds Three Months to Review of Takeda's New Drug Application for TAK-390MR 2Health News:Gladstone scientists identify role of fatty acids in Alzheimer's disease 2
(Date:11/6/2009)..., NATICK, Mass., Nov. 6 ... announced that it has reached an agreement in pri...elated to product advisories issued by its Guidant...uct sales occurred prior to Boston Scientific,s 20... had previously disclosed an investigation by the ...
(Date:11/6/2009)..., WINNIPEG, Manitoba, Nov. 6 With...arack Obama has set his sights on cutting name-bra...are patients who fall into the "Part D" coverage g...vocates rave about the potential cost-cutting and ... Yet some of the most powerful lobbyists want a re...
(Date:11/6/2009)..., RESEARCH TRIANGLE PARK, N.C., Nov. 6 /PRNewswir...advancing orally-available antiviral therapeutics ...dates on the development of the company,s lead ant...ization (WHO) and the Global Health Security Initi...l agent being developed for the treatment of small...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 1Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 2Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 4Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 1Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 2Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 3High HIV infection rate among Soweto Township gays 55664 1High HIV infection rate among Soweto Township gays 55664 2
...plore the Efficacy of Novel Proteasome Inhibitor i...ltiple Myeloma, SOUTH SAN FRANCISCO, Calif. and N...rch Consortium (MMRC) and Proteolix, Inc. today,an...ulti-center Phase 2,clinical trial to study Proteo...arfilzomib (PR-171), in patients with relapsed and...
...ade Possible by Early Investment by Cystic Fibrosi...SDA, Md., Aug. 15 Gilead Sciences,Inc., one of th... Parion,Sciences, Inc., a development-stage pharma...elop Parion 680, a compound that could become an i...cystic fibrosis. This product was,identified as pa...
Other Medicine Technology:The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4Promising Cystic Fibrosis Compound on Track for Development 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: